Zydus Life Zydus Lifesciences has received final approval from the US Food and Drug Administration (USFDA) to manufacture Eluxadoline Tablets, 75 mg and 100 mg. As per the chart stock made a Bullish doji candlestick pattern and gives a breakout of that. Chart is attached.

#WatchOutFor#Today’sTradingSetup#StockInNews#FundamentalViews#TechnicalViews

253 likes·54 comments